Md Abdul Latif
Education:
02.2017-03.2020:Degree: PhD
PhD thesis: Gene and immunotherapy of brain tumor
Institution: Dept. of Biomedicine, University of Bergen, Norway
2014-2016: Degree: Master in Medical Cell Biology
Master thesis: Targeting the AKT pathway in glioblastoma multiforme
Institution: Dept. of Biomedicine, University of Bergen, Norway
2007-2012: Degree: Bachelor in Biotechnology and Genetic Engineering
Institution: Mawlana Bhashani Science and Technology University, Bangladesh
Work Experience:
09.2022-Present: Job position: Head Engineer / Senior Engineer
Institution: Faculty of Biosciences, Nord University
04.2022-08.2022:Job position: Head Engineer
Institution: Dept. of Clinical Science (K1), University of Bergen
11.2020-03.2022:Job position: Head Engineer
Institution: Dept. of Clinical Science (K2), University of Bergen
Key Qualifications:
Broad experience in cell biology, molecular biology and immunology research including work with DNA, RNA, protein, immune assays, microscopy (fluorescence and confocal), histology, MRI, multicolour flow cytometry, implantation (mice and rats), transfection, lentivirus mediated gene modification of cell lines, iPS cell culture, bacteria culture, next generation sequencing (Miseq) and high throughput data analysis (RNAseq).
Lab Course: Aquatic Microbiology (BIO2001)
Institution: Nord University
Research Experiences (Projects involved):
10.2025-present: Title: In-vitro assessment of nutraceutical bioactivities of algal extracts in mammalian cells
My contribution: Writing project proposal in co-operation with group leader, performing and supervising in-vitro studies
09.2022- present: Title: Exploring the link between mitochondria and microbes during inflammatory bowel disease - the zebrafish model
My contribution: Isolation of microorganisms from the intestine and 16S-data analysis. Characterization of the intestinal cell population using imaging flow cytometry and mitochondrial respiration assays
11.2020-01.2022: Title: Prenatal BRCA1 methylation and breast and risk of ovarian cancer
My contribution: Running next generation sequencing machines (Miseq), isolating DNA/RNA, fragmenting DNA using COVARIS, quantifying DNA/RNA using qubit, qPCR, bioanalyzer etc.
06.2018-12.2019: Title: In-vitro and in-vivo modelling of a patient-derived primary central nervous system (CNS) lymphoma
My contribution: Performing xenografting, MRI, kinase array, induced pluripotent stem cell culture (iPS)
10.2017-12.2019: Title: HSV-TK/GCV suicide gene therapy of glioblastoma induces an immunosuppressive micro-environment
My contribution: Performing immunohistochemistry, flow cytometry, ELIspot assay, immunoblotting etc.
02.2017-12.2018: Title: Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma
My contribution: Performing MRI, immunoblotting, RNAseq data analysis etc.
08.2015-06.2016: Title: Targeting the AKT pathway in glioblastoma multiforme
My contribution: Performing cell culture, cell viability assay, clonogenic assay, immunoblotting, flow cytometry etc.
06.2015-07.2015: Title: Thioridazine sensitizes glioblastoma cells to temozolomide by impairing autophagy
My contribution: Performing co-immunoprecipitation, immuno-blotting, immunocytochemistry etc.
07.2013-07.2014: Title: Diversity analysis of jute genome by randomly amplified polymorphic DNA (RAPD) markers